609 related articles for article (PubMed ID: 37033972)
1. Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis.
Glover A; Zhang Z; Shannon-Lowe C
Front Immunol; 2023; 14():1161848. PubMed ID: 37033972
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of LOX-1
Li X; Li JL; Jiang N; Chen J; Liang ZM; Zhao ZL; Xing YF
Aging (Albany NY); 2020 Dec; 13(1):437-449. PubMed ID: 33290259
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the Relationship between SARS-CoV-2 and Cancer.
Costanzo M; De Giglio MAR; Roviello GN
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175509
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Autophagy in Cells Infected With Oncogenic Human Viruses and Its Impact on Cancer Development.
Vescovo T; Pagni B; Piacentini M; Fimia GM; Antonioli M
Front Cell Dev Biol; 2020; 8():47. PubMed ID: 32181249
[TBL] [Abstract][Full Text] [Related]
5. The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis.
Bayik D; Lee J; Lathia JD
Exp Suppl; 2022; 113():189-217. PubMed ID: 35165865
[TBL] [Abstract][Full Text] [Related]
6. Human Oncogenic Viruses: Characteristics and Prevention Strategies-Lessons Learned from Human Papillomaviruses.
Galati L; Chiantore MV; Marinaro M; Di Bonito P
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543781
[TBL] [Abstract][Full Text] [Related]
7. Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.
Saha A; Kaul R; Murakami M; Robertson ES
Cancer Biol Ther; 2010 Nov; 10(10):961-78. PubMed ID: 21084867
[TBL] [Abstract][Full Text] [Related]
8. The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment.
Dzobo K
OMICS; 2021 Jun; 25(6):358-371. PubMed ID: 34037476
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenesis and diagnostic practice applied in two oncogenic viruses: Epstein Barr virus and T-cell lymphotropic virus-1-Mini review.
Manivannan AC; Devaraju V; Velmurugan P; Sathiamoorthi T; Sivakumar S; Subbiah SK; Ravi AV
Biomed Pharmacother; 2021 Oct; 142():111974. PubMed ID: 34343895
[TBL] [Abstract][Full Text] [Related]
10. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effects of myeloid-derived suppressor cells in diseases: Role in cancer and infections.
Tamadaho RSE; Hoerauf A; Layland LE
Immunobiology; 2018; 223(4-5):432-442. PubMed ID: 29246400
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular interplay in virus-induced tumors in solid organ recipients.
Gallo A; Miele M; Badami E; Conaldi PG
Cell Immunol; 2019 Sep; 343():103770. PubMed ID: 29523417
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-Derived Suppressor Cells: The Expanding World of Helminth Modulation of the Immune System.
Stevenson MM; Valanparambil RM; Tam M
Front Immunol; 2022; 13():874308. PubMed ID: 35757733
[TBL] [Abstract][Full Text] [Related]
14. Oncogenes and RNA splicing of human tumor viruses.
Ajiro M; Zheng ZM
Emerg Microbes Infect; 2014 Sep; 3(9):e63. PubMed ID: 26038756
[TBL] [Abstract][Full Text] [Related]
15. Human viral oncogenesis: a cancer hallmarks analysis.
Mesri EA; Feitelson MA; Munger K
Cell Host Microbe; 2014 Mar; 15(3):266-82. PubMed ID: 24629334
[TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer.
Tcyganov EN; Hanabuchi S; Hashimoto A; Campbell D; Kar G; Slidel TW; Cayatte C; Landry A; Pilataxi F; Hayes S; Dougherty B; Hicks KC; Mulgrew K; Tang CA; Hu CA; Guo W; Grivennikov S; Ali MA; Beltra JC; Wherry EJ; Nefedova Y; Gabrilovich DI
J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34228641
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?
Goh C; Narayanan S; Hahn YS
Immunol Rev; 2013 Sep; 255(1):210-21. PubMed ID: 23947357
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers.
Fan R; De Beule N; Maes A; De Bruyne E; Menu E; Vanderkerken K; Maes K; Breckpot K; De Veirman K
Front Immunol; 2022; 13():1016059. PubMed ID: 36304465
[TBL] [Abstract][Full Text] [Related]
19. CD205
Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S
Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883
[TBL] [Abstract][Full Text] [Related]
20. STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion.
Zhang CX; Ye SB; Ni JJ; Cai TT; Liu YN; Huang DJ; Mai HQ; Chen QY; He J; Zhang XS; Zeng YX; Li J; Cui J
Cell Death Differ; 2019 Nov; 26(11):2314-2328. PubMed ID: 30816302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
